For episode 5 of the pharmaphorum podcast Dominic Tyer met Blueberry Therapeutics’ CEO Dr John Ridden at The Wellcome Collection in London to talk about the UK biotech he co-founded, its strategy and bringing innovation to life through Blueberry’s nanomedicine approach.
CinCor Pharma: A small pharma’s journey to acquisition
AI trends in 2023
Accelerating digital healthcare, with VITA
Investing in healthcare’s future, with Paul Tunnah and Elia Stupka
Solving problems in pathology data, with Nathan Buchbinder
How Moderna kept diversity in mind amid vaccine development
Key themes from JP Morgan, with Paul Tunnah
Cancer control in a time of crisis
The scattered seeds of the beginnings of change
A few of the 2022’s biggest pharma trends
Exploring the importance we play in our own health maintenance
Focusing on the evolution of biotechnology and R&D
Innovations in Real-World Evidence (live from PharmStars)
Continuing to keep COVID-19 at bay
Can VR technology make physical therapy fun
Exploring a united vision for British pharma at Anthropy
What we heard and saw at HLTH22, with Matthew Holt
Disrupting the standard of healthcare for Bangladesh
How immersive audio can be a therapeutic tool
A new hope in cachexia and an outsider’s view on pharma
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Short Wave
Stuff To Blow Your Mind
Unexplainable
Ground Truths